|
General Information
|
|
|
Product
|
Cytokeratin 20 Peptide
|
|
Description
|
Antigenic Blocking Peptide keratin, type I cytoskeletal 20 Antibody N-epitope
|
|
Verified Applications
|
Immunodepletion, Immunocompetition
|
|
Peptide Description
|
Synthetic Peptide
|
|
Accession #
|
NCBI: NP_061883.1
|
|
Physical Properties
|
|
|
Quantity
|
250 µg
|
|
Volume
|
100 µl
|
|
Form
|
Antigenic Blocking Peptide
|
|
Determinant
|
N-epitope
|
|
Storage
|
-20⁰C for long term storage
|
|
Application Protocol
|
|
Competition/Depletion assay
|
Refer to competition assay protocol
|
|
Protein
|
|
Uniprot #
|
P35900
|
|
Overview
|
Plays a role in maintaining keratin filament organization in intestinal epithelia. When phosphorlyated it is involved in the secretion of mucin in the small intestine.
|
|
Molecular Function
|
Structural constituent of cytoskeleton; Apoptosis
|
|
Subcellular Location
|
Cytoplasm
|
|
Expression
|
Mainly expressed in the itenstinal epithelium, expressed in luminal cells of colonic mucosa. Also expressed in Merkel cells of keratinzed oral mucosa.
|
|
Structure
|
Heterotetramer of two type I and two type II keratins, associates with KRT8.
|
|
Alternative Nomenclature
|
CD20 antibody
CK20 antibody
Cytokeratin20 antibody
K20 antibody
Keratin 20 antibody
keratin 21, rat, homolog of antibody
Keratin antibody
Keratin type I cytoskeletal 20 antibody
KRT20 antibody
KRT21 antibody
Protein IT antibody
type I cytoskeletal 20 antibody
|
| |
|
Cytokeratin 20 Antibody
Cytokeratin 20 Antibody FITC
Cytokeratin 20 Antibody BIOTIN
Cytokeratin 20 Positive Control
